Related Experiment Video
Updated: Apr 24, 2026

Stimulation of Notch Signaling in Mouse Osteoclast Precursors
Published on: February 28, 2017
A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia
Daniel Herranz1, Alberto Ambesi-Impiombato1, Teresa Palomero2
1Institute for Cancer Genetics, Columbia University, New York, New York, USA.
Abstract:
Efforts to identify and annotate cancer driver genetic lesions have been focused primarily on the analysis of protein-coding genes; however, most genetic abnormalities found in human cancer are located in intergenic regions. Here we identify a new long range-acting MYC enhancer controlled by NOTCH1 that is targeted by recurrent chromosomal duplications in human T cell acute lymphoblastic leukemia (T-ALL). This highly conserved regulatory element, hereby named N-Me for NOTCH MYC enhancer, is located within a broad super-enhancer region +1.47 Mb from the MYC transcription initiating site, interacts with the MYC proximal promoter and induces orientation-independent MYC expression in reporter assays. Moreover, analysis of N-Me knockout mice demonstrates a selective and essential role of this regulatory element during thymocyte development and in NOTCH1-induced T-ALL. Together these results identify N-Me as a long-range oncogenic enhancer implicated directly in the pathogenesis of human leukemia and highlight the importance of the NOTCH1-MYC regulatory axis in T cell transformation and as a therapeutic target in T-ALL.
Insights
Researchers discovered a novel MYC enhancer, N-Me, crucial for NOTCH1-driven T cell acute lymphoblastic leukemia (T-ALL). This long-range element, duplicated in T-ALL, drives MYC expression and is vital for thymocyte development.
Area of Science:
- Genomics
- Cancer Biology
- Molecular Oncology
Background:
- Focus on protein-coding genes for cancer driver lesions overlooks intergenic abnormalities.
- The role of non-coding regulatory elements in oncogenesis is increasingly recognized.
Purpose of the Study:
- To identify and characterize novel genetic lesions in intergenic regions of human cancers.
- To investigate the regulatory mechanisms driving MYC expression in T cell acute lymphoblastic leukemia (T-ALL).
Main Methods:
- Identification of a novel long-range enhancer (N-Me) using genomic analysis.
- Reporter assays to assess N-Me's regulatory function on MYC expression.
- Analysis of N-Me knockout mice to determine its role in thymocyte development and T-ALL.
Main Results:
- A new long-range MYC enhancer, N-Me, controlled by NOTCH1, was identified.
- N-Me is targeted by chromosomal duplications in human T-ALL and interacts with the MYC promoter.
- N-Me knockout mice exhibit defects in thymocyte development and resistance to NOTCH1-induced T-ALL.
Conclusions:
- N-Me is a critical long-range oncogenic enhancer in T-ALL pathogenesis.
- The NOTCH1-MYC regulatory axis is essential for T cell transformation and represents a potential therapeutic target in T-ALL.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Notch Signaling Pathway
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Induced Pluripotent Stem Cells
Somatic...
Abnormal Proliferation
Canonical Wnt Signaling Pathway

